EviVet IncoVet Syrup, 40 mg/ml, Dogs

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Phenylpropanolamine, Phenylpropanolamine Hydrochloride

Available from:

Vetoquinol UK Ltd

ATC code:

QG04BX91

INN (International Name):

Phenylpropanolamine, Phenylpropanolamine Hydrochloride

Pharmaceutical form:

Syrup

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Dogs

Therapeutic area:

Neurological Agent

Authorization status:

Authorized

Authorization date:

2022-02-25

Summary of Product characteristics

Issued: February 2022
AN: 01040/2021
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
EviVet IncoVet Syrup, 40 mg/ml, dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substance:
Phenylpropanolamine
40.28 mg
(Equivalent to 50 mg phenylpropanolamine hydrochloride)
Excipients:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Syrup.
Colourless to slightly yellow-brown solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of urinary incontinence associated with urethral sphincter
incompetence in
the bitch.
Efficacy has only been demonstrated in ovariohysterectomised bitches.
4.3
CONTRAINDICATIONS
The use of IncoVet is not appropriate for the treatment of behavioural
causes of
inappropriate urination. Do not administer to patients treated with
non-selective
monoamine oxidase inhibitors.
Do not use in case of known hypersensitivity to active substance or to
any of the
excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Issued: February 2022
AN: 01040/2021
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
i)
Special precautions for use in animals
Phenylpropanolamine,
a
sympathomimetic
drug,
may
affect
the
cardiovascular
system, especially blood pressure and heart rate, and should be used
with caution in
animals with cardiovascular diseases.
Care should be exercised in treating animals with severe renal or
hepatic insufficiency,
diabetes
mellitus,
hyperadrenocorticism,
glaucoma,
hyperthyroidism
or
other
metabolic disorders.
In bitches less than 1 year old the possibility of anatomical
disorders contributing to
incontinence should be considered prior to treatment.
ii)
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Phenylpropanolamine Hydrochloride is toxic when overdoses are
ingested. Adverse
effects may include dizziness, headache, nausea, insomnia or
restlessness, and
increased blood pressure. High ove